Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...
Patent
1980-09-18
1982-06-01
Milestone, Norma S.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Parasitic organism or component thereof or substance...
546234, A61K 31445, C07D21134
Patent
active
043328032
ABSTRACT:
4-Hydroxy-3-methoxy-N-[2-[2-(1-methyl-2-piperidinyl)ethyl]-phenyl]benzamide is an antiarrhythmic agent having relatively low toxicity and increased duration of action.
REFERENCES:
patent: 3931195 (1976-01-01), Dykstra et al.
S. J. Dykstra et al., Jour. Med. Chem. (1973) vol. 16, No. 9, pp. 1015-1020.
J. E. Byrne et al., Jour. Pharm. and Exper. Therapeutics (1977), vol. 200, No. 1, pp. 147-154.
R. F. Mayol et al., Therap. Drug Monitoring, vol. 1, pp. 507-524 (1979).
USAN and the USP Dictionary of Drug Names (1980) p. 122.
Gammans Richard E.
Mayol Robert F.
Carnahan Robert E.
Mead Johnson & Company
Milestone Norma S.
Uloth Robert H.
LandOfFree
Benzanilide derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzanilide derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzanilide derivative will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1849515